InvestorsHub Logo

BTH

Followers 16
Posts 4145
Boards Moderated 1
Alias Born 06/11/2010

BTH

Re: DonShimoda post# 3007

Friday, 10/29/2010 8:25:41 AM

Friday, October 29, 2010 8:25:41 AM

Post# of 80490

While some on this board insist the company should partner now and start global head to head, multi-arm trials



Who's insisting on that?

I would think Ariad would need to be approved in any indication for CML before they did something like that.

The only reason for a larger partner at this point is to start in other indications like solid-tumors.



Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.